The market cap is now only about 20M. It was over US$1B years ago, just before the disappointing PBT2 results. IMO, it is easy to predict perhaps even a similar big reaction now in January, not perhaps to a billion but a few hundred million, possibly. PBT2 was a potential AD drug and now ATH434 is only an MSA drug, but it still has a lot of potential in many other diseases, even including AD if it is safe. So to get the market cap to a 100M share price should go almost 5 fold the present. Interesting to follow during the next 7-8 weeks. The Maxim Group predicts the share price to be 8 and the consensus estimates are 6 dollars (ATHE). These are less than my prediction but they are professionals. I am only guessing.
ATH Price at posting:
0.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)